Clinical and Therapeutical Importance of HBV Genotyping in Romania
Author Information
Author(s): Constantinescu I, Nedelcu F, Toader MA, Vasile D
Primary Institution: Centre for Immunogenetics and Virology, Fundeni Clinical Institute
Hypothesis
The study aimed to identify the circulating HBV genotypes in Romania and correlate them with clinical outcomes.
Conclusion
HBV genotyping is crucial for selecting appropriate antiviral therapy and understanding the clinical outcomes of HBV infections.
Supporting Evidence
- HBV A genotype is associated with inactive carrier status.
- HBV D genotype is the most common and linked to active infection and hepatocellular carcinoma.
- Long-term chronic HBV infection often shows a mixture of A and D genotypes.
Takeaway
This study looked at 130 patients to find out which types of the hepatitis B virus are common in Romania and how they affect people's health.
Methodology
Patients were tested for various HBV markers, and HBV genotyping was performed using specific amplification and genotyping kits.
Participant Demographics
130 patients with varying stages of HBV infection, including asymptomatic carriers and those with chronic hepatitis and hepatocellular carcinoma.
Want to read the original?
Access the complete publication on the publisher's website